American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Immatics N.V. (IMTX)

$6.69 +4.21% NASDAQ: IMTX · 15-min delayed

Public · NASDAQ: IMTX
407 employees

Visit website Follow

$1.2BMarket cap

407Employees

IMTXNASDAQ

2020IPO

About Immatics N.V.

Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Company facts

Type: Public · NASDAQ: IMTX
Employees: 407
IPO date: Jul 2, 2020
Industry: Pharmaceuticals
Website: Visit site

Incorporation record

Incorporated in: NL — outside the United States
Registered office: Tübingen, DE
Legal entity ID: 984500DC691EZ96AF394

Source: GLEIF, the global Legal Entity Identifier registry · checked Aug 8, 2026. A US headquarters does not always mean US incorporation.

Is Immatics N.V. an American company? No. Immatics N.V. is incorporated in the Netherlands. It maintains US operations and its shares trade on NASDAQ — which is why it is often mistaken for a US company.

Registry IDs

Ticker: IMTX Nasdaq
SEC CIK: 1809196
LEI: 984500DC691EZ96AF394
SIC: 2836 Biological Products, (No Diagnostic Substances)

Explore our data studies: the biggest company in every US state · all rankings & reports.

Embed this company’s badge

Show Immatics N.V.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/immatics-nv/"><img src="https://americancompanies.com/badge/immatics-nv.svg" alt="Immatics N.V. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it free, control the page, and activate the embeddable Verified badge for their own website.

Claim this profile — free

Track American companies

Create a free account to follow Immatics N.V. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Market cap: $1.2B

NASDAQ: IMTX

$6.69 +4.21%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$6.18 $11.87

52-week range

Market cap: $1.2B
Shares outstanding: 185.5M
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: Jul 2, 2020

Immatics N.V. (IMTX) Stock Price

Trading 44% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Immatics N.V..

Write a review

Newsroom

News about Immatics N.V.

Immatics (IMTX) Reports Q3 Loss, Lags Revenue Estimates Zacks Investment Research · 2026-11-10 · negative Immatics Announces Third Quarter 2026 Financial Results and Business Update GlobeNewswire Inc. · 2026-11-10 · positive Immatics (IMTX) Expected to Beat Earnings Estimates: Can the Stock Move Higher? Zacks Investment Research · 2026-11-09 · positive CG Oncology, Inc. (CGON) Reports Q3 Loss, Beats Revenue Estimates Zacks Investment Research · 2026-11-06 · positive Immatics Presents Clinical Activity of IMA402 PRAME Bispecific and IMA203CD8 PRAME Cell Therapy across Advanced Solid Tumors in Two Oral Presentations at 2026 ESMO Annual Meeting GlobeNewswire Inc. · 2026-10-24 · positive Immatics Announces $150 Million Underwritten Offering GlobeNewswire Inc. · 2026-08-25 · neutral

News & sentiment via Polygon.io

FAQ

Immatics N.V.: frequently asked questions

Is Immatics N.V. an American company?

No — Immatics N.V. is not an American company. Immatics N.V. is incorporated in the Netherlands. It maintains US operations and its shares trade on NASDAQ — which is why it is often mistaken for a US company.

Where is Immatics N.V. incorporated?

Immatics N.V. is legally incorporated in the Netherlands, according to its GLEIF legal-entity record.

Is Immatics N.V. traded on a US stock exchange?

Yes — Immatics N.V. trades under the ticker IMTX on the NASDAQ. A US stock listing does not by itself make a company American — incorporation and ownership are what this page reports.

Is Immatics N.V. publicly traded?

Yes — Immatics N.V. is a publicly traded company. Its stock trades under the ticker symbol IMTX on the NASDAQ.

What does Immatics N.V. do?

Immatics N.V. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore